Ireland
--:--IST
Priya Life Science Medicines register
Registers› Irish medicines ›Mirena 52 mg Intrauterine Delivery System
Medicines register · Ireland

Mirena 52 mg Intrauterine Delivery System

Authorisation PPA0465/292/001 · PCO Manufacturing Ltd.

Source: Health Products Regulatory Authority (HPRA), open dataset, CC BY 4.0. HPRA list dated 22 Nov 2026
Licence holder
PCO Manufacturing Ltd. (all products →)
Active substance
Levonorgestrel
Clinical trials
3 clinical trials →
Dosage form
Intrauterine delivery system
Route of administration
Intrauterine use
ATC code
G02BA03
First authorised
24/08/2012
Prescription status
Product subject to prescription which may be renewed (B)
Supply
Supply through pharmacies only
Legal basis
Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC

Levonorgestrel: supply and approvals

26 authorised products on the HPRA list contain Levonorgestrel. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 21 Nov 2026)
US shortage (FDA)
No entry in the FDA drug shortage list (checked 21 Nov 2026)
Germany (BfArM)
2 supply notices, e.g. Levosert 20 Mikrogramm/24 Stunden intrauterines Wirkstofffreisetzungssystem (22 Jun 2026 to 31 Dec 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

About this licence

Parallel import (PPA). A parallel product authorisation: the HPRA allows this product to be imported from another EU or EEA country and sold in Ireland. It has been authorised for 14 years (since 24 August 2012). The HPRA list does not say whether it is on sale.

Other medicines with Levonorgestrel in Ireland

25 other products on the HPRA list contain Levonorgestrel, from 9 licence holders; 13 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
Jaydess 13.5 mg intrauterine delivery systemBayer LimitedNational authorisation (PA)Marketed
Kyleena 19.5 mg intrauterine delivery systemBayer LimitedNational authorisation (PA)Marketed
Leonore 100 micrograms/20 micrograms coated tabletsRowex Limited,National authorisation (PA)Marketed
Levonorgestrel Rowex 1.5mg TabletRowex Limited,National authorisation (PA)Marketed
Logynon TabletsBayer LimitedNational authorisation (PA)Marketed
Logynon TabletsBayer LimitedNational authorisation (PA)Marketed
Logynon TabletsBayer LimitedNational authorisation (PA)Marketed
Microlite 100 microgram/20 microgram coated tabletsBayer LimitedNational authorisation (PA)Marketed
Mirena 52 mg intrauterine delivery systemBayer LimitedNational authorisation (PA)Marketed
Ovranette 150 micrograms/30 micrograms coated tabletsPfizer Healthcare Ireland Unlimited CompanyNational authorisation (PA)Marketed
Ovreena 30 micrograms/150 micrograms coated tabletsGedeon Richter PlcNational authorisation (PA)Marketed
Ramonna 1500 microgram TabletGedeon Richter PlcNational authorisation (PA)Marketed

All 26 products with Levonorgestrel →

The licence holder

PCO Manufacturing Ltd. holds 288 products on the HPRA list, with 164 different active substances; 1 of the products is marked as marketed.

Shortages and approvals, every Friday

One email a week with ongoing EU and US medicine shortages, new EMA and FDA approvals and clinical trials recruiting in Ireland.

Free. Unsubscribe from any email with one click. See our privacy policy.

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.

How this page is built

The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.

This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.